Laparoscopic radical cystectomy in a patient with second primary post-robot-assisted radical prostatectomy
DOI:
https://doi.org/10.48193/revistamexicanadeurologa.v83i1.979Keywords:
cystectomy, Urethral carcinoma, urethrectomy, ileal conduit, prostate cancerAbstract
Case description: It describes the etiology, clinical scenario, and diagnosis of a patient with primary bulbar urethral carcinoma with history of a prostate cancer treated by Robot-assisted radical prostatectomy, actually treated with cystectomy, intracorporeal ileal conduit by laparoscopy, and total urethrectomy.
Relevance: Very few reported cases in medical literature and the important benefits of the minimally invasive surgery we observed in our work center in patients with a history of surgical interventions.
Clinical implications: Importance of narrow oncological surveillance and the benefit in postoperative recovery of a patient treated by minimal invasive procedures.
Conclusions: Every patient with an oncological diagnosis must have a narrow follow to detect the recurrence of the primary disease or new disease in a different place and if possible, always offer our patient a minimally invasive approach to diminish morbidity and mortality rate.
References
Visser O, Adolfsson J, Rossi S, Verne J, Gatta G, Maffezzini M, et al. Incidence and survival of rare urogenital cancers in Europe. European Journal of Cancer. 2012;48(4):456–64. doi: https://doi.org/10.1016/j.ejca.2011.10.031
Swartz MA, Porter MP, Lin DW, Weiss NS. Incidence of primary urethral carcinoma in the United States. Urology. 2006;68(6):1164–8. doi: https://doi.org/10.1016/j.urology.2006.08.1057
Van de Voorde W, Meertens B, Baert L, Lauweryns J. Urethral squamous cell carcinoma associated with urethral stricture and urethroplasty. Eur J Surg Oncol. 1994;20(4):478–83.
Cupp MR, Malek RS, Goellner JR, Espy MJ, Smith TF. Detection of human papillomavirus DNA in primary squamous cell carcinoma of the male urethra. Urology. 1996;48(4):551–5. doi: https://doi.org/10.1016/S0090-4295(96)00246-4
Compérat E, Varinot J. Immunochemical and molecular assessment of urothelial neoplasms and aspects of the 2016 World Health Organization classification. Histopathology. 2016;69(5):717–26. doi: https://doi.org/10.1111/his.13025
Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. 8th ed. Wiley-Blackwell; 2017. 272 p.
Gheiler EL, Tefilli MV, Tiguert R, Oliveira JG de, Pontes JE, Wood DP. Management of primary urethral cancer. Urology. 1998;52(3):487–93. doi: https://doi.org/10.1016/S0090-4295(98)00199-X
Touijer AK, Dalbagni G. Role of voided urine cytology in diagnosing primary urethral carcinoma. Urology. 2004;63(1):33–5. doi: https://doi.org/10.1016/j.urology.2003.08.007
Donat SM, Wei DC, McGuire MS, Herr HW. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol. 2001;165(5):1580–4. doi: https://doi.org/10.1097/00005392-200105000-00039
Kakizoe T, Tobisu K. Transitional Cell Carcinoma of the Urethra in Men and Women Associated with Bladder Cancer. Japanese Journal of Clinical Oncology. 1998;28(6):357–9. doi: https://doi.org/10.1093/jjco/28.6.357
Gakis G, Witjes JA, Compérat E, Cowan NC, De Santis M, Lebret T, et al. EAU Guidelines on Primary Urethral Carcinoma. European Urology. 2013 Nov 1;64(5):823–30. doi: https://doi.org/10.1016/j.eururo.2013.03.044
Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Clark PE, et al. Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2017;15(10):1240–67. doi: https://doi.org/10.6004/jnccn.2017.0156
Dayyani F, Pettaway CA, Kamat AM, Munsell MF, Sircar K, Pagliaro LC. Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists. Urologic Oncology: Seminars and Original Investigations. 2013;31(7):1171–7. doi: https://doi.org/10.1016/j.urolonc.2012.01.011
Zinman LN, Vanni AJ. Management of Proximal Primary Urethral Cancer: Should Multidisciplinary Therapy Be the Gold Standard? Urologic Clinics of North America. 2016;43(4):505–13. doi: https://doi.org/10.1016/j.ucl.2016.06.011
Sánchez de Badajoz E, Gallego Perales JL, Reche Rosado A, Gutiérrez de la Cruz JM, Jiménez Garrido A. Radical cystectomy and laparoscopic ileal conduit. Arch Esp Urol. 1993;46(7):621–4.
Matin SF, Gill IS. Laparoscopic Radical Cystectomy with Urinary Diversion: Completely Intracorporeal Technique. Journal of Endourology. 2002;16(6):335–41. doi: https://doi.org/10.1089/089277902760261338
Haber G-P, Campbell SC, Colombo JR, Fergany AF, Aron M, Kaouk J, et al. Perioperative outcomes with laparoscopic radical cystectomy: ‘pure laparoscopic’ and ‘open-assisted laparoscopic’ approaches. Urology. 2007;70(5):910–5. doi: https://doi.org/10.1016/j.urology.2007.07.012
